FKRP and neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan: Our genome‐editing strategy can be applied to precisely correct these FKRP missense mutations and by implication small insertion/deletion mutations (INDELs), as well as similar type of mutations in other dystroglycanopathy genes.